Tumori 2015; 101(Suppl. 1): 1 - 1
Article Type: INTRODUCTION
AuthorsAngelo Paradiso, Filippo Belardelli, Paolo De Paoli, Ruggero De Maria
- • Accepted on 02/12/2015
- • Available online on 30/12/2015
- • Published in print on 31/12/2015
This article is available as full text PDF.
Cancer remains one of the leading causes of death worldwide (1), urgently requiring efforts to better coordinate, also at the European level, the utilization of resources, research activities, and investments (2). However, the quality of care and access to information on standards of care are unequally distributed among various countries (3). This situation limits the possibility to proceed with harmonization and improvement plans among various institutes at the European level.
The Organisation of European Cancer Institutes (OECI), coordinating more than 70 European cancer institutes, recently developed an original program for voluntary accreditation of excellence of cancer centers (4), accreditation now received by 22 European Institutions. In Italy, the Comprehensive Cancer Centers, characterized by translational research activities and multidisciplinary organization, are recognized by the Ministry of Health of Italian Government as oncologic Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS). In 2010, the Ministry of Health supported a challenging project aiming to verify the applicability of the OECI model for accreditation of excellence to all oncologic IRCCS aggregated in the national network Alleanza Contro il Cancro (5). The projects ended in November 2015 with the certification of all the Institutes, thus characterizing Italy as the only European nation applying a tailored cancer model for accreditation to excellence to all its cancer institutes in a country-wide reality.
In this volume, we collect reports from those Institutes, describing peculiarities of their accreditation process, limitations and strengths of the model, and perspectives originating from this experience. We hope the results will be utilized by each institute for benchmarking considerations and by the Italian Ministry of Health to invest energies in critical areas this project put in evidence.
- Paradiso, Angelo [PubMed] [Google Scholar] 1, * Corresponding Author (firstname.lastname@example.org)
- Belardelli, Filippo [PubMed] [Google Scholar] 2
- De Paoli, Paolo [PubMed] [Google Scholar] 3
- De Maria, Ruggero [PubMed] [Google Scholar] 4
Scientific Project Coordinator, Istituto Tumori G. Paolo II, IRCCS, National Cancer Institure, Bari - Italy
Project Manager, Istituto Superiore Sanità, Rome - Italy
Board Member of Accreditation&Designation WG OECI, Centro di Riferimento Oncologico (CRO), IRCCS, National Cancer Institute, Aviano (Pordenone) - Italy
President of Alleanza contro il Cancro, Istituto Regina Elena, IRCCS, Regina Elena National Cancer Institute, Rome - Italy